This compound is primarily utilized in the field of medicinal chemistry and pharmaceutical research. It serves as a key intermediate or active ingredient in the development of targeted therapeutic agents, particularly for conditions involving the central nervous system. Its structural features, including the trifluoromethyl group and naphthalene moiety, make it suitable for interacting with specific biological receptors or enzymes, potentially leading to the treatment of neurological disorders or chronic pain. Additionally, it may be explored in the synthesis of novel compounds for drug discovery programs aimed at addressing unmet medical needs.